Pharmacological administration of recombinant human AMH rescues ovarian reserve and preserves fertility in a mouse model of chemotherapy, without interfering with anti-tumoural effects
Author(s) -
Hadassa Roness,
Itay Spector,
Yael LeichtmannBardoogo,
Angela Maria Savino,
Sanaz Dereh-Haim,
Dror Meirow
Publication year - 2019
Publication title -
journal of assisted reproduction and genetics
Language(s) - English
Resource type - Journals
eISSN - 1573-7330
pISSN - 1058-0468
DOI - 10.1007/s10815-019-01507-9
Subject(s) - ovarian reserve , anti müllerian hormone , ovary , biology , ovarian follicle , follicle , fertility preservation , endocrinology , medicine , in vivo , population , hormone , fertility , infertility , pregnancy , genetics , microbiology and biotechnology , environmental health
To determine whether pharmacological administration of recombinant human anti-Mullerian hormone (rAMH) protects the ovarian reserve and preserves fertility without interfering with anti-tumoural cytotoxic action of chemotherapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom